Dr. Rob Carlson is the Managing Director of Bioeconomy Capital. Rob is also a Principal at Biodesic, a strategy, engineering, and security consulting firm in Seattle that provides services to governments and corporations around the globe.
At the broadest level, Dr. Carlson is interested in the future role of biology as a human technology. He has worked to develop new biological technologies in both academic and commercial environments, focusing on molecular measurement and microfluidic systems. Dr. Carlson has also developed a number of new technical and economic metrics for measuring the progress of biological technologies. Carlson is the author of the book Biology is Technology: The Promise, Peril, and New Business of Engineering Life, published in 2010 by Harvard University Press; it received the PROSE award for the Best Engineering and Technology Book of 2010 and was named to the Best Books of 2010 lists by writers at both The Economist and Foreign Policy. He is a frequent international speaker and has served as an advisor to such diverse organizations as The Hastings Center, the PICNIC Design Festival, the UN, the OECD, the US Government, and companies ranging in size from startups to members of the Fortune 100. Carlson earned a doctorate in Physics from Princeton University in 1997.